Cited by 1,097Schizophrenia research and treatmentPsychometric Methodologies and TestingMental Health and Psychiatry

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Morosini, P.L., Magliano, L., Brambilla, L., Ugolini, S., Pioli, R.·2000·Acta Psychiatrica Scandinavica

DOI 10.1034/j.1600-0447.2000.101004323.x

Open this paper in CoChat — free account

Abstract

Morosini P‐L, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning. Acta Psychiatr Scand 2000: 101:323–329. © Munksgaard 2000. Objective: Development of a scale to assess patients' social functioning, the Personal and Social Performance scale (PSP). Method: PSP has been developed through focus groups and reliability studies on the basis of the social functioning component of the DSM‐TV Social and Occupational Functioning Assessment Scale (SOFAS). The last reliability study was carried out by 39 workers with different professional roles on a sample of 61 psychiatric patients admitted to the rehabilitation unit. Each patient was rated independently on the scale by the two workers who knew them best. Results: The PSP is a 100–point single‐item rating scale, subdivided into 10 equal intervals. The ratings are based mainly on the assessment of patient's functioning in four main areas: 1) socially useful activities; 2) personal and social relationships; 3) self‐care; and 4) disturbing and aggressive behaviours. Operational criteria to rate the levels of disabilities have been defined for the above‐mentioned areas. Excellent inter‐rater reliability was also obtained in less educated workers. Conclusion: Compared to SOFAS, PSP has better face validity and psychometric properties. It was found to be an acceptable, quick and valid measure of patients' personal and social functioning.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0447.2000.101004323.x

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Diagnostic and Statistical Manual of Mental Disorders
Sciacca, F., Sharma, R., & Knipe, H. (2020) · Radiopaedia.org · doi:10.53347/rid-80880 · Cited by 2,395
Health Measurement Scales: A Practical Guide To Their Development And Use
Streiner, D. L., & Norman, G. R. (2003) · doi:10.1093/oso/9780198528470.001.0001 · Cited by 1,460
Revising axis V for DSM-IV: a review of measures of social functioning
Goldman, H. H., Skodol, A. E., & Lave, T. R. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1148 · Cited by 1,408
A quality of life interview for the chronically mentally ill
Lehman, A. F. (1988) · Evaluation and Program Planning · doi:10.1016/0149-7189(88)90033-x · Cited by 1,085
A Brief Mental Health Outcome Scale
Jones, S. H., Thornicroft, G., Coffey, M., & Dunn, G. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.5.654 · Cited by 1,019
Burden on the families of patients with schizophrenia: results of the BIOMED I study
Magliano, L., Fadden, G., Madianos, M. G., Caldas‐de‐Almeida, J. M., Held, T., Guarneri, M., Marasco, C., Tosini, P., & Maj, M. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050073 · Cited by 308
Self-citation
Dr. Goldman Replies
GOLDMAN, M. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.1119-a · Cited by 285
Evidence for limited validity of the revised global assessment of functioning scale
Roy‐Byrne, P., Dagadakis, C. S., Unützer, J., & Ries, R. R. (1996) · Psychiatric Services · doi:10.1176/ps.47.8.864 · Cited by 106

Show all 12 references

Research works printed but not linked: 7

Morosini PL, 1988, Disabiliti sociale e carico familiare: studio di riproducibilità di un nuovo strumento di valutazione, Riv Speriment Fren, 112, 541
Morosini PL, 1991, Routine assessment tools in psychiatry: a questionnaire on family attitudes and burden, Ital J Psychiatr Behav Sci, 1, 95
Magliano L, 1993, Studio di riproducibilità di un' intervista semi‐strutturata per l'accertamento della disabilità sociale e del carico familiare (ADC), Riv Riabilitaz Psichiatr Psicosoc, 2, 49
Morosini PL, 1998, VADO — Valu tazione di Abilita, Definizione di Obiettivi
Moroslini PL, 1996, Prima validazione ed applicazione di uno strumento clinico‐epidemiologico per valutare gli esiti nella riabilitazione psichiatrica: DI. SA, Disabilita e Salute, Riv Speriment Fren, 5, 817
1992, Stata — Statistics/graphics/data management
1997, SPSS — Statistical Package for Social Sciences

Sorted by citations

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
People living with psychotic illness in 2010: the second Australian national survey of psychosis
Morgan, V. A., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J. J., Carr, V., Bush, R., Castle, D., Cohen, M., Harvey, C., et al. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449877 · Cited by 504
Positive Health
Seligman, M. E. P. (2008) · Applied Psychology · doi:10.1111/j.1464-0597.2008.00351.x · Cited by 614
Disability and employment–overview and highlights
Vornholt, K., Villotti, P., Muschalla, B., Bauer, J., Colella, A., Zijlstra, F., Van Ruitenbeek, G., Uitdewilligen, S., & Corbière, M. (2018) · European Journal of Work and Organizational Psychology · doi:10.1080/1359432x.2017.1387536 · Cited by 407
Assessment of Adult Psychopathology: Meta-Analyses and Implications of Cross-Informant Correlations.
Achenbach, T. M., Krukowski, R. A., Dumenci, L., & Ivanova, M. Y. (2005) · Psychological Bulletin · doi:10.1037/0033-2909.131.3.361 · Cited by 406
A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
Kane, J. M., Skuban, A., Ouyang, J., Hobart, M., Pfister, S., McQuade, R. D., Nyilas, M., Carson, W. H., Sanchez, R., & Eriksson, H. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.038 · Cited by 325
Social functioning as an outcome measure in schizophrenia studies
Burns, T., & Patrick, D. M. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01108.x · Cited by 322
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
Paliperidone for schizophrenia
Dolder, C. R., Nelson, M., & Deyo, Z. M. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070261 · Cited by 252
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial
Morrison, A. P., Turkington, D., Pyle, M., Spencer, H. M., Brabban, A., Dunn, G., Christodoulides, T., Dudley, R. E. J., Chapman, N., Callcott, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62246-1 · Cited by 265
Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study
Davidson, M., Emsley, R. A., Kramer, M. L., Ford, L., Pan, G., Lim, P., & Eerdekens, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.003 · Cited by 249
Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia
Nasrallah, H., Morosini, P., & Gagnon, D. D. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.012 · Cited by 243
Self-citation
Efficacy and Safety of Paliperidone Extended-Release Tablets: Results of a 6-Week, Randomized, Placebo-Controlled Study
Marder, S. R., Kramer, M. L., Ford, L., Eerdekens, E., Lim, P., Eerdekens, M., & Lowy, A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.017 · Cited by 228
A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia
Pandina, G., Lindenmayer, J., Lull, J., Lim, P., Gopal, S., Herben, V. M. M., Kusumakar, V., Yuen, E., & Palumbo, J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181dd3103 · Cited by 214
Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia
Rosenheck, R. A., Krystal, J. H., Lew, R., Barnett, P. G., Fiore, L. D., Valley, D., Thwin, S. S., Vertrees, J. E., & Liang, M. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005987 · Cited by 213
Recovery and serious mental illness: a review of current clinical and research paradigms and future directions.
Leonhardt, B. L., Huling, K., Hamm, J. A., Roe, D., Hasson-Ohayon, I., McLeod, H. J., & Lysaker, P. H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1378099 · Cited by 195
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
Correll, C. U., Skuban, A., Ouyang, J., Hobart, M., Pfister, S., McQuade, R. D., Nyilas, M., Carson, W. H., Sanchez, R., & Eriksson, H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101275 · Cited by 183
Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis
Stain, H. J., Galletly, C. A., Clark, S., Wilson, J., Killen, E. A., Anthes, L., Campbell, L. E., Hanlon, M.-C., & Harvey, C. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449060 · Cited by 178
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Iasevoli, F., Giordano, S., Balletta, R., Latte, G., Formato, M. V., Prinzivalli, E., Berardis, D. D., Tomasetti, C., & de Bartolomeis, A. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.010 · Cited by 178
Psychometric properties of the Questionnaire about the Process of Recovery (QPR)
Law, H., Neil, S. T., Dunn, G., & Morrison, A. P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.011 · Cited by 172
Maintenance treatment with antipsychotic drugs for schizophrenia
Ceraso, A., Lin, J., Schneider‐Thoma, J., Siafis, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Davis, J. M., & Leucht, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub3 · Cited by 184
A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia
Nasrallah, H. A., Gopal, S., Gassmann-Mayer, C., Quiroz, J. A., Lim, P., Eerdekens, M., Yuen, E., & Hough, D. W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.79 · Cited by 169
Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis
Cooper, J., Mancuso, S. G., Borland, R., Slade, T. N., Galletly, C. A., & Castle, D. J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449876 · Cited by 172
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
Harvey, P. D., Bosia, M., Cavallaro, R., Howes, O. D., Kahn, R. S., Leucht, S., Müller, D., Penadés, R., & Vita, A. (2022) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2022.100249 · Cited by 185
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
Pandina, G., Lane, R., Gopal, S., Gassmann-Mayer, C., Hough, D. W., Remmerie, B. M. M., & Simpson, G. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.008 · Cited by 162
Targeted primary care‐based mental health services for young Australians
Scott, E. M., Hermens, D. F., Glozier, N., Naismith, S. L., Guastella, A. J., & Hickie, I. B. (2012) · Medical Journal of Australia · doi:10.5694/mja11.10481 · Cited by 155
Apathy, cognitive deficits and functional impairment in schizophrenia
Konstantakopoulos, G., Ploumpidis, D. N., Oulis, P., Patrikelis, P., Soumani, A., Papadimitriou, G. N., & Politis, A. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.003 · Cited by 150
Mapping Neural Circuit Biotypes to Symptoms and Behavioral Dimensions of Depression and Anxiety
Goldstein‐Piekarski, A. N., Ball, T. M., Samara, Z., Staveland, B. R., Keller, A. S., Fleming, S. L., Grisanzio, K. A., Holt-Gosselin, B., Stetz, P. C., Ma, J., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.06.024 · Cited by 155
Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression
Gyurak, A., Patenaude, B., Korgaonkar, M. S., Grieve, S. M., Williams, L. M., & Etkin, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.037 · Cited by 149
Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia.
Schreiner, A., Aadamsoo, K., Altamura, A. C., Franco, M., Gorwood, P., Neznanov, N. G., Schronen, J., Ucok, A., Zink, M., Janik, A., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.015 · Cited by 145
Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies
Bugarski‐Kirola, D., Blaettler, T., Arango, C., Fleischhacker, W., Garibaldi, G. M., Wang, A., Dixon, M., Bressan, R. A., Nasrallah, H. A., Lawrie, S. M., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.11.014 · Cited by 145
The “Functional Remission of General Schizophrenia” (FROGS) scale: Development and validation of a new questionnaire
Llorca, P., Lançon, C., Lancrenon, S., Bayle, F., Caci, H. M., Rouillon, F., & Gorwood, P. A. P. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.029 · Cited by 134
Improving Social Cognition in Schizophrenia: A Pilot Intervention Combining Computerized Social Cognition Training With Cognitive Remediation
Lindenmayer, J., McGurk, S. R., Khan, A., Kaushik, S., Thanju, A., Hoffman, L., Valdez, G., Wance, D., & Herrmann, E. M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs120 · Cited by 146
Prolonged exposure and EMDR for PTSDv. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders
de Bont, P. A. J. M., van den Berg, D. P. G., van der Vleugel, B. M., de Roos, C., de Jongh, A., van der Gaag, M., & van Minnen, A. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716001094 · Cited by 148
A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
Downing, A. M., Kinon, B. J., Millen, B. A., Zhang, L., Liu, L., Ma, M., Brenner, R., Rayle, T. J., Nisenbaum, L., Zhao, F., et al. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0351-3 · Cited by 129
Exercise as an intervention for first‐episode psychosis: a feasibility study
Firth, J., Carney, R., Elliott, R., French, P., Parker, S., McIntyre, R., McPhee, J. S., & Yung, A. R. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12329 · Cited by 140
Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE)
Egerton, A., Broberg, B. V., van Haren, N. E. M., Merritt, K., Barker, G. J., Lythgoe, D. J., Pérez‐Iglesias, R., Baandrup, L., Düring, S. W., Sendt, K.-V., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0082-9 · Cited by 127
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia
Patrick, D. L., Burns, T., Morosini, P., Rothman, M. L., Gagnon, D. D., Wild, D. J., & Adriaenssen, I. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802611919 · Cited by 126
Self-citation
Could schizophrenic subjects improve their social cognition abilities only with observation and imitation of social situations?
Mazza, M., Lucci, G., Pacitti, F., Pino, M. C., Mariano, M., CASACCHIA, M., & Roncone, R. (2010) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2010.486284 · Cited by 123
A systematic review and meta-analysis of low intensity CBT for psychosis
Hazell, C. M., Hayward, M., Cavanagh, K., & Strauss, C. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.03.004 · Cited by 120
Genotype–phenotype associations in children with copy number variants associated with high neuropsychiatric risk in the UK (IMAGINE-ID): a case-control cohort study
Chawner, S. J. R. A., Owen, M. J., Holmans, P., Raymond, F. L., Skuse, D., Hall, J., & van den Bree, M. B. M. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30123-3 · Cited by 129
The new approach: psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia
Juckel, G., & Morosini, P. L. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314e144 · Cited by 126
Self-citation
‘Earning and learning’ in those with psychotic disorders: The second Australian national survey of psychosis
Waghorn, G., Saha, S., Harvey, C. A., Morgan, V. A., Waterreus, A. J., Bush, R. A. B., Castle, D. J., Galletly, C. A., Stain, H. J., Neil, A. L., et al. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412452015 · Cited by 123
Recovery-focused cognitive–behavioural therapy for recent-onset bipolar disorder: Randomised controlled pilot trial
Jones, S. H., Smith, G., Mulligan, L. D., Lobban, F., Law, H., Dunn, G., Welford, M., Kelly, J., Mulligan, J., & Morrison, A. P. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.141259 · Cited by 118
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis
Morgan, V. A., Waterreus, A. J., Carr, V. J., Castle, D. J., Cohen, M. A., Harvey, C. A., Galletly, C. A., Mackinnon, A. J., McGorry, P. D., McGrath, J. J., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416679738 · Cited by 123
Social skills and behavioral problems in schizophrenia: The role of mental state attribution, neurocognition and clinical symptomatology
Brüne, M., Schaub, D., Juckel, G., & Langdon, R. A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.015 · Cited by 113
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial
Morrison, A. P., Pyle, M., Gumley, A. I., Schwannauer, M., Turkington, D., MacLennan, G., Norrie, J. D., Hudson, J., Bowe, S. E., French, P., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30184-6 · Cited by 124
Risk constellations prior to the development of bipolar disorders: Rationale of a new risk assessment tool
Leopold, K., Ritter, P. S., Correll, C. U., Marx, C., Özgürdal, S., Juckel, G., Bauer, M., & Pfennig, A. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.043 · Cited by 110
Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia
Juckel, G., Schaub, D., Fuchs, N., Naumann, U., Uhl, I., Witthaus, H., Hargarter, L., Bierhoff, H., & Brüne, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.037 · Cited by 110
Evaluating the Psychometric Quality of Social Skills Measures: A Systematic Review
Cordier, R., Speyer, R., Chen, Y.-W. R., Wilkes‐Gillan, S., Brown, T., Bourke‐Taylor, H. M., Doma, K., & Leicht, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132299 · Cited by 112
Standardised rating scales in Psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales
Möller, H.-J. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802264606 · Cited by 107
The Danish High Risk and Resilience Study – VIA 7 - a cohort study of 520 7-year-old children born of parents diagnosed with either schizophrenia, bipolar disorder or neither of these two mental disorders
Thorup, A. A. E., Jepsen, J. R. M., Ellersgaard, D., Burton, B. K., Christiani, C. J., Hemager, N., Skjærbæk, M., Ranning, A., Spang, K. S., Gantriis, D. L., et al. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0616-5 · Cited by 111
Predictors of help-seeking behaviour in people with mental health problems: a 3-year prospective community study
Doll, C. M., Michel, C., Rosen, M., Osman, N., SCHIMMELMANN, B. G., & Schultze‐Lutter, F. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03435-4 · Cited by 114
Symptomatic remission in schizophrenia patients: Relationship with social functioning, quality of life, and neurocognitive performance
Brissos, S., Dias, V. V., Balanzá‐Martínez, V., Carita, A. I., & Figueira, M. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.04.001 · Cited by 106
Adiposity and Eating Behaviors in Patients Under Second Generation Antipsychotics
Blouin, M., Tremblay, A., Jalbert, M.-E., Venables, H. D. S., Bouchard, R.-H., Roy, M., & Alméras, N. (2008) · Obesity · doi:10.1038/oby.2008.277 · Cited by 104
Safety and Tolerability of Oral Paliperidone Extended-Release Tablets in Elderly Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study With Six-Month Open-Label Extension
Tzimos, A., Самохвалов, В. П., Kramer, M. L., Ford, L., Gassmann-Mayer, C., Lim, P., & Eerdekens, M. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31815a3e7a · Cited by 104
Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use
Large, M. M. B., Mullin, K., Gupta, P., Harris, A. W. F., & Nielssen, O. B. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414525838 · Cited by 104
The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial
Davey, C. G., Chanen, A. M., Hetrick, S. E., Cotton, S., Ratheesh, A., Amminger, G. P., Koutsogiannis, J., Phelan, M., Mullen, E., Harrison, B. J., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30215-9 · Cited by 104
Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
Durgam, S., Earley, W. R., Li, R., Li, D., Lu, K., Laszlovszky, I., Fleischhacker, W. W., & Nasrallah, H. A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.030 · Cited by 103
Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial
Corripio, I., Roldán, A., Sarró, S., McKenna, P. J., Alonso-Solís, A., Rabella, M., Díaz, A., Puigdemont, D., Pérez, V., Álvarez, E., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.029 · Cited by 111
N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 100
Negative symptoms and everyday functioning in schizophrenia: A cross-sectional study in a real world-setting
Rocca, P., Montemagni, C., Zappia, S., Piterà, R., Sigaudo, M., & Bogetto, F. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.018 · Cited by 101
The reliability, validity, and applicability of an English language version of the Mini-ICF-APP
Molodynski, A., Linden, M., Juckel, G., Yeeles, K., Anderson, C., Vazquez-Montes, M., & Burns, T. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0604-8 · Cited by 98
Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders
Breier, A. F., Liffick, E., Hummer, T. A., Vohs, J. L., Yang, Z., Mehdiyoun, N. F., Visco, A. C., Metzler, E., Zhang, Y., & Francis, M. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.012 · Cited by 99
The bipolar recovery questionnaire: psychometric properties of a quantitative measure of recovery experiences in bipolar disorder
Jones, S. H., Mulligan, L. D., Higginson, S., Dunn, G., & Morrison, A. P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.003 · Cited by 102
Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia
Jones, C. A., Hacker, D., Meaden, A., Cormac, I., & Irving, C. B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub3 · Cited by 97
Retracted
Spirituality, religiousness and coping in patients with schizophrenia: A cross sectional study in a tertiary care hospital
Das, S., Punnoose, V. P., Doval, N., & Nair, V. Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.030 · Cited by 94
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
Li, H., Rui, Q., Ning, X., Xu, H., & Gu, N. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.001 · Cited by 92
Functional outcome and social cognition in bipolar disorder: Is there a connection?
Vlad, M., Raucher‐Chéné, D., Henry, A., & Kaladjian, A. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.05.002 · Cited by 102
Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia
Jones, C. A., Hacker, D., Cormac, I., Meaden, A., & Irving, C. B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008712.pub2 · Cited by 109
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
Biase, M. A. D., Zalesky, A., O'Keefe, G. J., Laskaris, L., Baune, B. T., Weickert, C. S., Olver, J. S., McGorry, P. D., Amminger, G. P., Nelson, B., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.193 · Cited by 93
The Specific Level of Functioning Scale: construct validity, internal consistency and factor structure in a large Italian sample of people with schizophrenia living in the community.
Mucci, A., Rucci, P., Rocca, P., Bucci, P., Gibertoni, D., Merlotti, E., Galderisi, S., & Maj, M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.044 · Cited by 95
The Chinese version of the Personal and Social Performance Scale (PSP): Validity and reliability
Si, T., Shu, L., Su, Y., Chenghua, T., Yan, J., Cheng, J., Li, X., Qi, L., Ma, Y., Weihua, Z., et al. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.05.001 · Cited by 92
Interventions and social functioning in youth at risk of psychosis: A systematic review and meta‐analysis
Devoe, D. J. A., Farris, M. S., Townes, P., & Addington, J. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12689 · Cited by 88
Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
Fleischhacker, W. W., Hobart, M., Ouyang, J., Forbes, A., Pfister, S., McQuade, R. D., Carson, W. H., Sanchez, R., Nyilas, M., & Weiller, E. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw076 · Cited by 88
Relationships between psychiatric symptoms, functioning and personal recovery in psychosis
Best, M. W., Law, H., Pyle, M., & Morrison, A. P. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.026 · Cited by 91
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale
Mucci, A., Vignapiano, A., Bitter, I., Austin, S. F., Delouche, C., Dollfus, S., Erfurth, A., Fleischhacker, W. W., Giordano, G. M., Олегович, Г. И., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.05.006 · Cited by 85
The effect of duration of untreated psychosis and treatment delay on the outcomes of prolonged early intervention in psychotic disorders
Albert, N., Melau, M., Jensen, H., Hastrup, L. H., Hjorthøj, C. R., & Nordentoft, M. (2017) · Schizophrenia · doi:10.1038/s41537-017-0034-4 · Cited by 85
Brexpiprazole: so far so good
Das, S., Barnwal, P., Aruldhas, B. W., Mondal, S., & Saha, I. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315614739 · Cited by 84
Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies
Emsley, R. A., Berwaerts, J., Eerdekens, M., Kramer, M. L., Lane, R., Lim, P., Hough, D., & Palumbo, J. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328314e1f3 · Cited by 81
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study
Morrison, A. P., Law, H., Carter, L., Sellers, R., Emsley, R., Pyle, M., French, P., Shiers, D., Yung, A. R., Murphy, E., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30096-8 · Cited by 88
Amotivation and functional outcomes in early schizophrenia
Fervaha, G., Foussias, G., Agid, O., & Remington, G. J. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.024 · Cited by 82
Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: A feasibility study
Morrison, A. P., Pyle, M., Chapman, N., French, P., Parker, S. K., & Wells, A. (2014) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2013.11.003 · Cited by 82
Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia
Jones, C. A., Hacker, D., Meaden, A., Cormac, I., Irving, C. B., Xia, J., Zhao, S., Shi, C., & Chen, J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008712.pub3 · Cited by 85
A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
Umbricht, D., Keefe, R., Murray, S., Lowe, D., Porter, R., Garibaldi, G., & Santarelli, L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.17 · Cited by 77
Psychometric properties of the Personal and Social Performance scale (PSP) among individuals with schizophrenia living in the community
Kawata, A. K., & Revicki, D. A. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9400-z · Cited by 79
Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study
Gründer, G., Heinze, M., Cordes, J., Mühlbauer, B., Juckel, G., Schulz, C., Rüther, E., & Timm, J. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00085-7 · Cited by 85
Heterogeneity and symptom structure of schizophrenia
Picardi, A., Viroli, C., Tarsitani, L., Miglio, R., de Girolamo, G., Dell’Acqua, G., & Biondi, M. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.12.051 · Cited by 77
Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable
Garcia-Portilla, M. P., Saiz, P. A., Bousoño, M., Bascaran, M. T., Guzmán-Quilo, C., & Bobes, J. (2011) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2010.11.003 · Cited by 75
Cognitive therapy for people with a schizophrenia spectrum diagnosis not taking antipsychotic medication: an exploratory trial
Morrison, A. P., Hutton, P., Wardle, M., Spencer, H. M., Barratt, S., Brabban, A., Callcott, P., Christodoulides, T., Dudley, R. E. J., French, P., et al. (2011) · Psychological Medicine · doi:10.1017/s0033291711001899 · Cited by 78
Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study
Mizuno, Y., Hofer, A., Suzuki, T., Frajo-Apor, B., Wartelsteiner, F., Kemmler, G., Saruta, J., Tsukinoki, K., Mimura, M., Fleischhacker, W. W., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.047 · Cited by 73
Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis
Lam, M., Lee, J., Rapisarda, A., See, Y. M., Yang, Z., Lee, S.-A., Rashid, N. A. A., Kraus, M., Subramaniam, M., Chong, S., et al. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.1668 · Cited by 73
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
Martinuzzi, E., Barbosa, S., Daoudlarian, D., Ali, W. B. H., Gilet, C., Fillatre, L., Khalfallah, O., Troudet, R., Jamain, S., Fond, G. B., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0366-5 · Cited by 74
Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
Bojesen, K. B., Ebdrup, B. H., Jessen, K., Sigvard, A. K., Tangmose, K., Edden, R. A. E., Larsson, H. B. W., Rostrup, E., Broberg, B. V., & Glenthoj, B. Y. (2019) · Psychological Medicine · doi:10.1017/s0033291719002277 · Cited by 72
The effect of service satisfaction and spiritual well-being on the quality of life of patients with schizophrenia
Lanfredi, M., Candini, V., Buizza, C., Ferrari, C., Boero, M. E., Giobbio, G. M., Goldschmidt, N., Greppo, S., Iozzino, L., Maggi, P., et al. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.01.045 · Cited by 71
Project Synergy: co‐designing technology‐enabled solutions for Australian mental health services reform
Hickie, I. B., Davenport, T. A., Burns, J. M., Milton, A. C., Ospina‐Pinillos, L., Whittle, L., Ricci, C. S., McLoughlin, L. T., Mendoza, J. A., Cross, S. P. M., et al. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50349 · Cited by 72
Quetiapinev.lithium in the maintenance phase following a first episode of mania: Randomised controlled trial
Berk, M., Daglas, R., Dandash, O., Yücel, M., Henry, L. P., Hallam, K. T., Macneil, C. A., Hasty, M. K., Pantelis, C., Murphy, B., et al. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.116.186833 · Cited by 78
A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey
Mancuso, S. G., Morgan, V. A., Mitchell, P. B., Berk, M., Young, A. H., & Castle, D. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.035 · Cited by 70
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Berk, M., Mohebbi, M., Dean, O. M., Cotton, S., Chanen, A. M., Dodd, S., Ratheesh, A., Amminger, G. P., Phelan, M., Weller, A., et al. (2020) · BMC Medicine · doi:10.1186/s12916-019-1475-6 · Cited by 72
Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
Bojesen, K. B., Broberg, B. V., Fagerlund, B., Jessen, K., Thomas, M. B., Sigvard, A. K., Tangmose, K., Nielsen, M. Ø., Andersen, G. S., Larsson, H. B. W., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.027 · Cited by 71

Authors: Morosini, P. L., Magliano, L., Brambilla, L., Ugolini, S., & Pioli, R.
Corresponding author: Morosini, P.L.
ORCID: Magliano, L.
Venue: Acta Psychiatrica Scandinavica
Publisher: Wiley
Published: 2000-04
Volume: 101
Issue: 4
Pages: 323-329
ISSN: 0001-690X (ISSN-L)
1600-0447
DOI: 10.1034/j.1600-0447.2000.101004323.x
OpenAlex: W4244847179
Cited by: 1,097
References: 12
Citations by year: 2026: 30 · 2025: 47 · 2024: 40 · 2023: 70 · 2022: 100 · 2021: 86 · 2020: 154 · 2019: 80 · 2018: 77 · 2017: 57 · 2016: 73 · 2015: 56 · 2014: 44 · 2013: 47 · 2012: 32
FWCI: 0.23
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 632 d)
Locations: Acta Psychiatrica Scandinavica (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: SOFA, occupational functioning, psychometric validation, reliability statistics, acceptability, DSM-IV, psychiatric assessment instruments

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development, reliability and acceptability of a new version of the DSM‐IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks